We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 182

The unique risks of investing in out-of-network providers

  • McGuireWoods LLP
  • -
  • USA
  • -
  • December 10 2014

For several years, industry observers have been predicting the demise of out-of-network business models, yet they still survive. For some providers

October digital health investments dominated by diagnostics and therapeutics

  • Fenwick & West LLP
  • -
  • USA
  • -
  • December 2 2014

Digital health companies raised just over $730 million through venture, private equity and angel investments in September, according to our latest

The direction of the market

  • Weil Gotshal & Manges LLP
  • -
  • USA
  • -
  • November 30 2014

In a year where global M&A activity has boomed, the health care sector has emerged as one of the hottest industries for deal making, with over $400

Mobile health technologies rake in largest digital health investments of August

  • Fenwick & West LLP
  • -
  • USA
  • -
  • September 22 2014

The top five digital health investments in August accounted for nearly half of the venture, private equity and angel investments in the sector during

Tech investors eye healthcare data firms

  • McGuireWoods LLP
  • -
  • USA
  • -
  • September 18 2014

Technology investors, including VC firms and portfolio managers of large mutual funds, are increasingly targeting healthcare data firms as new

Digital health investments dominated by software plays in July

  • Fenwick & West LLP
  • -
  • USA
  • -
  • September 8 2014

Healthcare software dominates the list of top digital health investments in July. Of the 10 digital health companies that received venture, private

Is Valeant’s offer for Allergan the new roadmap for biopharma acquisitions?

  • Kaye Scholer LLP
  • -
  • USA
  • -
  • August 22 2014

Earlier this year, Valeant Pharmaceuticals International, Inc. teamed up with the hedge fund Pershing Square Capital Management, L.P. To acquire

Corporate venture funding for funding surges

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 7 2014

Silicon Valley Bank (SVB) has issued a report that explores health-care and biotech investments and exits based on 2013 data and concludes, "Large

Digital health investments top $2.6B in the first six months of 2014

  • Fenwick & West LLP
  • -
  • USA
  • -
  • July 31 2014

Thanks to an impressive showing in April, digital health investment in the first half of 2014 totaled $2.676 billion. There were a total of 38 deals

Keep the benefit of the bargain reps and warranties survival in healthcare deals

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • July 28 2014

In recent healthcare mergers and acquisitions, we have seen the parties increasingly focus on the survival length of the representations and